The University of Pennsylvania
Last Modified: June 17, 2003
Conference Dates: September 11-12, 2003
Conference Location: Philadelphia, PA
Sponsoring Group: The University of Pennsylvania Abramson Cancer Center and The School of Medicine
Topics Covered: This will be our sixth annual symposium devoted to the latest and most relevant care standards and changes in management of patients with breast cancer. This program continues to bring the best local, national, and international authorities on a broad array of subjects to Philadelphia to bridge the information presented at the May American Society of Clinical Oncology annual meeting, and the December San Antonio Breast Cancer Symposium. This year?s program will be expanded from the traditional one-day program to a one-and-one-half day program, allowing time to introduce topics for discussion.
Conference Objectives: This year, as in past years, we hope to provide our audience with the best and most timely information in the evolving world of breast cancer care.
Who Should Attend: This educational program is intended for breast surgeons, radiation oncologists, medical oncologists, oncology nurses, and other physicians and health care professionals in active clinical practice who are interested and/or involved in the management of patients with breast cancer.
Registration Information: Registration is required. Registration deadline is Thursday, August 28, 2003. Checks must be received by Thursday, August 28, 2003. Registration form is available as a PDF.
Conference Fees: The registration fee is $225.00 for physicians and $125.00 for nurses and other health care professionals. Registration includes tuition, conference materials, lunch, and refreshment
Continuing Education: Yes. The University of Pennsylvania School of Medicine designates this continuing medical education activity for a maximym of 10.5 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
Mar 2, 2011 - Breast cancer incidence rates among non-Hispanic white women in the United States stabilized between 2003 and 2007 after a sharp decline between 2002 and 2003 that followed a drop in the use of postmenopausal hormone therapy, according to a study published online Feb. 28 in Cancer Epidemiology, Biomarkers & Prevention.
Mar 2, 2011
Apr 28, 2010